WinstonWınston
Back
Medartis Holding AG logo

Medartis Holding AG

MED.SW
51
Medical - Devices · Healthcare
Exchange
SIX Swiss Exchange
Winston Score
51
Winston is curious
Mixed quality — meaningful strengths and weaknesses.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Good
Growth
Mixed
Cash Flow
Strong
Stability
Mixed
Valuation
Good

Winston Score History

The full picture

Medartis is a Swiss medical device company that makes small metal plates, screws, and implants used to fix broken bones. Surgeons use these products during operations on hands, wrists, feet, ankles, and faces. The company sells its devices to hospitals and surgical centers, competing in the orthopedic and maxillofacial fixation market.

Medartis makes money by selling its implants and the specialized instruments that go with them, typically through a direct sales force in key markets. The company operates mainly in Europe, with growing presence in North America and other international markets. Its competitive edge comes from precision Swiss engineering and a focus on smaller, more complex bones that larger rivals sometimes overlook. However, the very thin operating margin of around 0.4% shows the company is spending heavily to expand its sales infrastructure, and turning that investment into consistent profit is the central challenge the business faces right now.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+30.7% YoY

YoY Growth Rate

Revenue accelerating

EPS Growth

+441.7% YoY

YoY Growth Rate

EPS growth accelerating

Insider Activity

67.4%ownership

Rising

Insiders increasing their stake — aligned with shareholders

Cash Runway

~8 months

CHF 27M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Short runway — potential dilution ahead through share issuance

Revenue accelerating

Medartis Holding AG grew revenue 31% year-over-year and the growth rate is speeding up. That's the kind of momentum growth investors look for — the question is whether margins can follow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
81.7%
Premium pricing power — 81.7% gross margin
Profit after running costs
Operating Margin
8.2%
Modest — 8.2% operating margin
Return on the money invested
ROCE
1.0%
Weak — 1.0% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+29.9%
Fast-growing sales (+29.9% YoY)
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
198%
Turns 198% of profit into real cash
Spare cash per sale
FCF Margin
0.4%
Thin free cash flow (0.4%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.74
Moderate — manageable debt (0.74)
Covers its interest
Interest Cover
0.47x
Dangerous — barely covers interest (0.5x)

Interest coverage below 1. Their profits don't cover the interest bill.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
79.8x
no trend
Expensive — P/E 79.8

P/E over 35. The market is pricing in heavy, sustained growth.

Cheaper or dearer next year
P/E vs Forward
+40.6
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (79.8 → 39.3)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial